BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 73 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q3 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,118,914 | -43.2% | 3,525,754 | 0.0% | 0.20% | -40.8% |
Q2 2023 | $17,805,058 | +263.7% | 3,525,754 | +36.1% | 0.34% | +202.7% |
Q1 2023 | $4,894,919 | +5.0% | 2,589,904 | 0.0% | 0.11% | +16.8% |
Q4 2022 | $4,661,827 | +6.5% | 2,589,904 | 0.0% | 0.10% | +2.2% |
Q3 2022 | $4,377,000 | -31.3% | 2,589,904 | 0.0% | 0.09% | -45.3% |
Q2 2022 | $6,371,000 | -11.2% | 2,589,904 | 0.0% | 0.17% | +8.3% |
Q1 2022 | $7,174,000 | -48.0% | 2,589,904 | 0.0% | 0.16% | -35.4% |
Q4 2021 | $13,804,000 | -37.0% | 2,589,904 | 0.0% | 0.24% | -20.1% |
Q3 2021 | $21,911,000 | -30.6% | 2,589,904 | 0.0% | 0.30% | -40.0% |
Q2 2021 | $31,571,000 | -49.8% | 2,589,904 | 0.0% | 0.51% | -46.5% |
Q1 2021 | $62,831,000 | -24.3% | 2,589,904 | 0.0% | 0.95% | -18.4% |
Q4 2020 | $83,006,000 | +6.0% | 2,589,904 | 0.0% | 1.16% | -19.0% |
Q3 2020 | $78,293,000 | -28.3% | 2,589,904 | 0.0% | 1.43% | -32.7% |
Q2 2020 | $109,190,000 | +69.0% | 2,589,904 | 0.0% | 2.13% | +4.3% |
Q1 2020 | $64,618,000 | – | 2,589,904 | – | 2.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 634,191 | $1,820,128 | 2.14% |
NEA Management Company, LLC | 4,448,757 | $12,767,933 | 0.99% |
CHI Advisors LLC | 720,000 | $2,066,400 | 0.82% |
Bellevue Group AG | 8,135,839 | $23,349,858 | 0.38% |
Parkman Healthcare Partners LLC | 520,587 | $1,494,085 | 0.27% |
Artal Group S.A. | 2,046,517 | $5,874 | 0.25% |
RA Capital Management | 3,525,754 | $10,118,914 | 0.20% |
Ikarian Capital, LLC | 555,572 | $1,594,492 | 0.19% |
TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,148,000 | 0.16% |
Newtyn Management, LLC | 205,000 | $588,350 | 0.14% |